KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,141 | +445.9% | 6,745 | +598.2% | 0.01% | +550.0% |
Q2 2023 | $209 | -87.0% | 966 | -89.1% | 0.00% | -89.5% |
Q1 2023 | $1,604 | +7.4% | 8,828 | +16.1% | 0.02% | +5.6% |
Q4 2022 | $1,494 | -99.9% | 7,601 | +6.8% | 0.02% | -10.0% |
Q3 2022 | $1,601,000 | -37.3% | 7,118 | -64.7% | 0.02% | -25.9% |
Q2 2022 | $2,552,000 | +140.1% | 20,172 | +140.5% | 0.03% | +237.5% |
Q1 2022 | $1,063,000 | -25.7% | 8,387 | -23.2% | 0.01% | 0.0% |
Q4 2021 | $1,431,000 | +90.8% | 10,925 | +78.3% | 0.01% | +100.0% |
Q3 2021 | $750,000 | +97.9% | 6,129 | +84.2% | 0.00% | +100.0% |
Q2 2021 | $379,000 | -42.5% | 3,328 | -39.3% | 0.00% | -33.3% |
Q1 2021 | $659,000 | -87.7% | 5,483 | -89.6% | 0.00% | -89.3% |
Q4 2020 | $5,338,000 | +112.4% | 52,545 | +61.7% | 0.03% | +75.0% |
Q3 2020 | $2,513,000 | +169.9% | 32,499 | +289.2% | 0.02% | +100.0% |
Q2 2020 | $931,000 | +226.7% | 8,351 | +111.3% | 0.01% | +166.7% |
Q1 2020 | $285,000 | – | 3,952 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |